 Efficacy safety intravenous nicardipine control postoperative hypertension IV Nicardipine Study Group double-blind study efficacy safety intravenous IV nicardipine placebo control postoperative hypertension cardiac noncardiac surgical patients twenty-two patients cardiac noncardiac surgery entry criteria systolic BP equal mm Hg diastolic BP equal mm Hg IV nicardipine placebo Therapeutic response equal percent reduction BP baseline percent patients IV vs percent placebo mean response time infusion rate IV nicardipine minutes mg/h magnitude BP reduction similar cardiac noncardiac postsurgical patients Blood pressure control minimal dose adjustments IV nicardipine mg/h prolonged maintenance infusion period reflex mean increase heart rate bpm patients IV nicardipine Sixteen patients noncardiac cardiac surgery sustained heart rate bpm mean increase bpm baseline patients tachycardia nicardipine None patients development tachycardia nicardipine therapy ST segment changes ischemia patient tachycardia baseline ST segment depression mm nicardipine treatment following discontinuation nicardipine therapy application nitroglycerin Nitropaste Hemodynamic evaluation IV mean arterial pressure systemic vascular resistance cardiac index change heart rate hemodynamic changes similar cardiac noncardiac surgical patients Adverse experiences IV nicardipine hypotension percent percent percent placebo group incidence adverse experience percent equal distribution hypotension percent percent headache percent important changes laboratory variables IV nicardipine conclusion findings nicardipine titratable intravenous calcium channel blocker postoperative hypertension cardiac noncardiac surgical patients